FIELD: infectology.
SUBSTANCE: intended for antibacterial therapy. An antibacterial pharmaceutical composition suitable for intravenous administration contains: (a) 2 grams of cefepime or a pharmaceutically acceptable salt thereof, (b) 2 grams of tazobactam or a pharmaceutically acceptable salt thereof, and (c) 1.4 grams to 1.6 grams of arginine, or its pharmaceutically acceptable salt, where the pH of the composition is in the range from 6 to 8 before intravenous administration.
EFFECT: providing a therapeutic synergistic antibacterial composition that can be administered without causing phlebitis.
8 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL COMPOSITIONS AND METHODS | 2017 |
|
RU2779346C2 |
| COMPOSITIONS CONTAINING ANTIBACTERIAL AGENT AND TAZOBACTAM | 2011 |
|
RU2593363C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2014 |
|
RU2702361C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2560846C1 |
| COMPOSITIONS AND METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2676482C2 |
| 1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
| CEFTAROLINE-INCLUDING COMPOSITIONS AND METHODS OF TREATMENT | 2009 |
|
RU2524665C2 |
| 1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
